Suppr超能文献

Ki-67 标记指数作为输卵管浆液性上皮内癌诊断的辅助指标。

Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma.

机构信息

Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.

出版信息

Int J Gynecol Pathol. 2012 Sep;31(5):416-22. doi: 10.1097/PGP.0b013e31824cbeb4.

Abstract

There is mounting evidence that serous tubal intraepithelial carcinoma (STIC) may be the immediate precursor of ovarian high-grade serous carcinoma (HGSC) but the criteria for its diagnosis are not well established as highlighted in a recent study showing that interobserver reproducibility, even among expert gynecologic pathologists, was moderate at best. Given the clinical significance of a diagnosis of STIC in a patient who has no other evidence of ovarian carcinoma, this is a serious issue that we felt needed to be addressed. Although it is not clear, at this time, whether such a patient should or should not be treated, the importance of an accurate and reproducible diagnosis of precursors of ovarian carcinoma cannot be underestimated. We hypothesized that an elevated Ki-67 labeling index may aid the diagnosis of STIC. Accordingly, we compared the Ki-67 index of STIC and HGSC to normal fallopian tube epithelium (FTE) in the same patients and to a control group of patients without carcinoma, matched for age. A total of 41 STICs were analyzed, of which 35 were associated with a concurrent HGSC. In FTE, immunoreactivity for Ki-67 was restricted to a few scattered cells (mean 2.0%). No statistically significant difference was found between patients with and without HGSC (P>0.05). However, both STICs and HGSC had significantly higher Ki-67 indices than normal FTE (P<0.0001). STICs uniformly had an elevated Ki-67 labeling index that ranged from 11.7% to 71.1% (average 35.6%). There was no correlation of the Ki-67 labeling index in the STICs and the associated HGSC, as the labeling index was lower in STIC in 18/35 (51.4%) whereas it was higher in 17/35 (48.6%) (P=0.86). In conclusion, the findings in this study indicate that compared with FTE, STICs have a significantly higher Ki-67 index similar to HGSC. Accordingly, the Ki-67 index can aid the diagnosis of intraepithelial tubal proliferations suspicious for STIC. Therefore, we propose that a Ki-67 index of 10% is a useful diagnostic tool to distinguish STICs from normal FTE.

摘要

越来越多的证据表明,输卵管上皮内浆液性癌(STIC)可能是卵巢高级别浆液性癌(HGSC)的直接前体,但由于最近的一项研究表明,即使在专家级妇科病理学家中,其诊断标准也没有得到很好的建立,因此其诊断标准仍未得到很好的建立。鉴于 STIC 诊断对没有其他卵巢癌证据的患者的临床意义,这是一个严重的问题,我们认为需要解决。尽管目前尚不清楚此类患者是否应该治疗,但对卵巢癌前体的准确和可重复诊断的重要性不容忽视。我们假设升高的 Ki-67 标记指数可能有助于 STIC 的诊断。因此,我们比较了同一患者的 STIC 和 HGSC 与正常输卵管上皮(FTE)以及与年龄匹配的无癌患者的对照组的 Ki-67 指数。共分析了 41 例 STIC,其中 35 例与同时发生的 HGSC 相关。在 FTE 中,Ki-67 的免疫反应性仅限于少数散在的细胞(平均值 2.0%)。在有或没有 HGSC 的患者之间未发现统计学上的显著差异(P>0.05)。然而,STIC 和 HGSC 的 Ki-67 指数均显著高于正常 FTE(P<0.0001)。STIC 普遍具有升高的 Ki-67 标记指数,范围为 11.7%至 71.1%(平均值 35.6%)。在 35 例 STIC 中,有 18 例(51.4%)的 STIC 中 Ki-67 标记指数较低,而有 17 例(48.6%)的 STIC 中 Ki-67 标记指数较高,两者之间无相关性(P=0.86)。总之,本研究的结果表明,与 FTE 相比,STIC 的 Ki-67 指数明显更高,与 HGSC 相似。因此,Ki-67 指数可有助于诊断可疑为 STIC 的上皮内输卵管增生。因此,我们建议 Ki-67 指数为 10%是区分 STIC 和正常 FTE 的有用诊断工具。

相似文献

1
Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma.
Int J Gynecol Pathol. 2012 Sep;31(5):416-22. doi: 10.1097/PGP.0b013e31824cbeb4.
4
The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma.
Am J Surg Pathol. 2012 Dec;36(12):1826-34. doi: 10.1097/PAS.0b013e31825ec07a.
5
Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma.
Gynecol Oncol. 2015 Oct;139(1):104-11. doi: 10.1016/j.ygyno.2015.07.100. Epub 2015 Jul 20.
6
[Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
Zhonghua Bing Li Xue Za Zhi. 2017 Aug 8;46(8):542-547. doi: 10.3760/cma.j.issn.0529-5807.2017.08.005.
8
Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions.
Am J Surg Pathol. 2024 Apr 1;48(4):475-486. doi: 10.1097/PAS.0000000000002187. Epub 2024 Feb 1.

引用本文的文献

2
High-grade serous ovarian cancer (HGSOC) with fallopian tube involvement.
Rom J Morphol Embryol. 2024 Apr-Jun;65(2):325-329. doi: 10.47162/RJME.65.2.20.
3
Histopathologic and Preneoplastic Changes in Tubal Ligation Materials.
Medicina (Kaunas). 2023 Dec 4;59(12):2117. doi: 10.3390/medicina59122117.
4
A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors.
Diagn Pathol. 2023 Feb 28;18(1):32. doi: 10.1186/s13000-023-01317-9.
5
Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation.
Nat Rev Cancer. 2022 Nov;22(11):640-656. doi: 10.1038/s41568-022-00503-z. Epub 2022 Sep 15.
6
The organoid: A research model for ovarian cancer.
Tzu Chi Med J. 2021 Jul 9;34(3):255-260. doi: 10.4103/tcmj.tcmj_63_21. eCollection 2022 Jul-Sep.
8
Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond and .
Cells. 2022 Feb 4;11(3):539. doi: 10.3390/cells11030539.
9
Pathologic Classification of Ovarian Cancer.
Methods Mol Biol. 2022;2424:11-40. doi: 10.1007/978-1-0716-1956-8_2.

本文引用的文献

1
Ovarian Cancer Is an Imported Disease: Fact or Fiction?
Curr Obstet Gynecol Rep. 2012 Mar;1(1):1-9. doi: 10.1007/s13669-011-0004-1.
5
Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications.
Int J Gynecol Pathol. 2010 Jul;29(4):310-4. doi: 10.1097/PGP.0b013e3181c713a8.
6
Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics.
J Oncol. 2010;2010:126295. doi: 10.1155/2010/126295. Epub 2010 Apr 27.
9
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.
Am J Surg Pathol. 2010 Mar;34(3):433-43. doi: 10.1097/PAS.0b013e3181cf3d79.
10
Precursors to pelvic serous carcinoma and their clinical implications.
Gynecol Oncol. 2009 Jun;113(3):391-6. doi: 10.1016/j.ygyno.2009.01.013. Epub 2009 Feb 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验